GENESIS Biomed 4th Anniversary

by GENESIS Biomed

5 years ago
GENESIS Biomed, biomedical research

GENESIS Biomed is celebrating its anniversary. We have been working for 4 years to transfer the results of biomedical research to the market.

Julio Mayol:'Research is one of the key points in the response to this pandemic'

by GENESIS Biomed

5 years ago
Julio Mayol, GENESIS Biomed, pandemic, hospitals

Interview Julio Mayol – Professor of Surgery at the Complutense University of Madrid and Medical Director of the San Carlos Clinical Hospital

Liberalización de las patentes de vacunas contra la COVID

by GENESIS Biomed

5 years ago
GENESIS Biomed, vacunas, patentes, Covid19

Artículo de Opinión de Bernabé Zea – Partner en ZBM Patents & Trademarks y miembro del Business Advisory Board de GENESIS Biomed

The Gregorio Marañón Hospital creates a spin-off to market the drug that protects the kidney

by GENESIS Biomed

5 years ago
Cilastatin project, kidney, Telara Pharma, GENESIS Biomed

The Cilastatin project arose thanks to the research carried out by the deceased Dr. Alberto Tejedor, who was Nephrology Service section chief at the Gregorio Marañón General University Hospital and ...

GENESIS Biomed provides support to different projects in the field of in vitro fertilisation

by GENESIS Biomed

5 years ago
Oxolife, DROPLITE, assisted reproductive, in vitro fertilisation

It is estimated that infertility affects over 75 million women around the world and over 3 million assisted reproductive techniques are performed each year. In Spain, assisted reproduction treatments ...

Elena Torrente interview – Digital Health Development Deputy Director DKV

by GENESIS Biomed

5 years ago
Elena Torrente, DKV, digital health

Elena Torrente has been working in the field of innovation and digital health for 15 years, in both the public and private sectors. She is currently deputy director of digital health development at DK...

GENESIS Biomed y DKV firman un acuerdo de colaboración para impulsar la salud digital

by GENESIS Biomed

5 years ago
Big Data, DKV Innolab, GENESIS Biomed, salud digital, Grupo DKV

La tecnología ocupa un papel esencial en el ámbito de la salud. La irrupción de la pandemia de la COVID-19 ha demostrado la necesidad de implantar un sistema de salud digital que facilite una atenc...

Josep Tabernero: 'The covid-19 has been a revulsive to value research and I hope that this will not change when the situation improves'

by GENESIS Biomed

5 years ago
Josep Tabernero, GENESIS Biomed, research

Dr. Josep Tabernero is one of the most recognized and prestigious figures in the field of oncology. He is one of the most cited researchers and his healthcare work has earned him recognition as one of...

GENESIS Biomed is reinforced by hiring a top-level advisory panel

by GENESIS Biomed

5 years ago
GENESIS Biomed, biomedicine

GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respe...

Research is the main tool we have against cancer

by GENESIS Biomed

5 years ago
cancer, research, diagnostics, drugs

Cancer is the second biggest cause of death throughout the world today. Every year 9.6 million people die from it, 65% of them in low- and medium-income countries. Spain shows a similar trend to other...

Sílvia Carrasco: 'The COVID-19 pandemic has highlighted the importance of research and tech transfer'

by GENESIS Biomed

5 years ago
health, COVID-19, research, technology transfer, Knowledge

Research is crucial for the development of any country, but so is the transformation of that knowledge into products or applications that benefit society. Knowledge and technology transfer are among t...

Six GENESIS Biomed clients feature in the 30 principal health science funding rounds in Catalonia

by GENESIS Biomed

5 years ago
health, funding rounds, biotechnology, medical technology, digital health

2020 was not an easy year. The COVID-19 pandemic seriously affected many sectors. Tourism, catering and the cultural industry were among those suffering serious setbacks and they still have to contend...